AMICUS THERAPEUTICS, INC. — Director's Dealing 2019

Oct 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2019-10-09

Reporting Person: Clark David Michael (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-09	Common Stock	F	6896	$7.48	Disposed	101161	Direct

Footnotes

F1: On October 9, 2018, the reporting person was granted 56,012 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. The number of shares reported on this line represent shares withheld following the first anniversary of the grant date.